By Paul Armentano, NORML The administration of cannabidiol (CBD), a nonpsychotropic cannabinoid, controls sleep disorders in patients with Parkinson’s disease (PD), according to a series of case summaries published in the Journal of Clinical Pharmacy and Therapeutics. An international team of investigators from the University of Sao Paulo, Brazil and the University of Minnesota Medical School …
Maintaining “robust” encendocannabinoid signaling – which can be done through through the intake of cannabinoids – may provide protection against stress and stress-related disorders, according to a new study published in the journal Seminars in Immunology, and published online by the National Institute of Health. According to the study, “CB1 receptor-endocannabinoid signaling is activated by …
A new study published in this month’s issue of the journal Kidney International, and published online by the U.S. National Institute of Health, has found that cannabinoid deficiency worsens diabetic nephropathy, a type of kidney disease, indicating that cannabinoid therapy may provide a treatment. “A functionally active endocannabinoid system is present within the kidney”, begins …
A new study being published in next month’s issue of the journal Atherosclerosis, and published online early by the National Institute of Health, has found that activation of the body’s cannabinoid receptors – something done naturally by cannabis – may provide a potential treatment option for atherosclerosis. Atherosclerosis, also known as vascular disease, is a fairly …
Follow Us!